01 1Alembic Pharmaceuticals Limited (API Division Panelav)
02 1Cipla Limited
03 1Samoh Pharmaceutical Co., Ltd.
01 1Samoh Pharmaceutical Co., Ltd.
02 1UNUST Co., Ltd.
03 1Zmax Pharmachem Co., Ltd.
01 3Leflunomide
01 2India
02 1Uzbekistan
Registrant Name : Zmax Pharmachem Co., Ltd.
Registration Date : 2022-04-25
Registration Number : 20220425-209-J-1225
Manufacturer Name : Alembic Pharmaceuticals Limi...
Manufacturer Address : AT-Panelav, Tal-Halol, City. Panelav, Dist.-Panchmahal, Gujarat State, India
Registrant Name : UNUST Co., Ltd.
Registration Date : 2020-09-22
Registration Number : 20200922-209-J-748
Manufacturer Name : Cipla Limited
Manufacturer Address : Old Madras Road, Virgonagar Post, Bangalore-560 049, India
Registrant Name : Samoh Pharmaceutical Co., Ltd.
Registration Date : 2019-12-11
Registration Number : 20191211-209-J-499
Manufacturer Name : Samoh Pharmaceutical Co., Lt...
Manufacturer Address : 63, Okgucheonseo-ro 81beon-gil, Siheung-si, Gyeonggi-do (705, 1-ma, Sihwa Industrial ...
55
PharmaCompass offers a list of Leflunomide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Leflunomide manufacturer or Leflunomide supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Leflunomide manufacturer or Leflunomide supplier.
PharmaCompass also assists you with knowing the Leflunomide API Price utilized in the formulation of products. Leflunomide API Price is not always fixed or binding as the Leflunomide Price is obtained through a variety of data sources. The Leflunomide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-, including repackagers and relabelers. The FDA regulates Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- supplier is an individual or a company that provides Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- active pharmaceutical ingredient (API) or Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- finished formulations upon request. The Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- suppliers may include Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- API manufacturers, exporters, distributors and traders.
click here to find a list of Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- Drug Master File in Korea (Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-. The MFDS reviews the Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- KDMF as part of the drug registration process and uses the information provided in the Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- KDMF to evaluate the safety and efficacy of the drug.
After submitting a Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]- suppliers with KDMF on PharmaCompass.
We have 3 companies offering Isoxazole-4-carboxamide, 5-methyl-N-[4-(trifluoromethyl)phenyl]-
Get in contact with the supplier of your choice:
